» Articles » PMID: 8550184

Role of Endotoxemia in Cardiovascular Dysfunction and Lethality: Virulent and Nonvirulent Escherichia Coli Challenges in a Canine Model of Septic Shock

Overview
Journal Infect Immun
Date 1996 Feb 1
PMID 8550184
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated whether the severity of septic shock is determined by virulence factors associated with or the levels of endotoxemia produced by two Escherichia coli strains. Canines were challenged intraperitoneally with an E. coli strain (O6:H1:K2) that has virulence factors associated with human disease or with an equal dose of a nonvirulent strain (O86:H8) that lacks these factors. Both strains were administered in viable, heat-killed, and purified endotoxin forms. Median survival times with the virulent strain compared with the nonvirulent strain were shorter with viable bacteria (5 x 10(10) CFU/kg) (144 h versus > 672 h; Wilcoxon, P = 0.03), longer with heat-killed bacteria (5 x 10(9) CFU/kg) ( > 676 h versus 26 h; P = 0.03), and similar with purified endotoxin (15 mg/kg) (28 h versus 48 h; P = 0.71). However, whether the challenge contained viable bacteria, heat-killed bacteria, or purified endotoxin, the virulent strain produced less endotoxemia (P = 0.001). Hence, the changing outcomes with differing forms of the two strains cannot be attributed solely to endotoxin levels. The viable virulent strain caused less endotoxemia but more harm, and this does not appear to be explained by a more potent endotoxin or other heat-stable component. This study suggests that circulating endotoxin levels per se are less important in the outcome of septic shock than virulence factors associated with E. coli strains. Furthermore, the data call into question the significance of the endotoxin concentration in the blood in predicting the severity of shock and the lethality of gram-negative infections.

Citing Articles

Endotoxemia as a diagnostic tool for patients with suspected bacteremia caused by gram-negative organisms: a meta-analysis of 4 decades of studies.

Hurley J, Nowak P, Ohrmalm L, Gogos C, Armaganidis A, Giamarellos-Bourboulis E J Clin Microbiol. 2015; 53(4):1183-91.

PMID: 25631796 PMC: 4365253. DOI: 10.1128/JCM.03531-14.


Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.

Hurley J Toxins (Basel). 2013; 5(12):2589-620.

PMID: 24351718 PMC: 3873702. DOI: 10.3390/toxins5122589.


Prognostic value of endotoxemia in patients with Gram-negative bacteremia is bacterial species dependent.

Hurley J, Opal S J Innate Immun. 2013; 5(6):555-64.

PMID: 23594418 PMC: 6741488. DOI: 10.1159/000347172.


Does gram-negative bacteraemia occur without endotoxaemia? A meta-analysis using hierarchical summary ROC curves.

Hurley J Eur J Clin Microbiol Infect Dis. 2010; 29(2):207-15.

PMID: 20084488 DOI: 10.1007/s10096-009-0841-2.


Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice.

Bailat S, Heumann D, Le Roy D, Baumgartner J, Rietschel E, Glauser M Infect Immun. 1997; 65(2):811-4.

PMID: 9009348 PMC: 176131. DOI: 10.1128/iai.65.2.811-814.1997.

References
1.
MCCLOSKEY R, Straube R, Sanders C, Smith S, Smith C . Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med. 1994; 121(1):1-5. DOI: 10.7326/0003-4819-121-1-199407010-00001. View

2.
Andersen B, SKJORTEN F, Solberg O . Electron microscopical study of Neisseria meningitidis releasing various amounts of free endotoxin. Acta Pathol Microbiol Scand B. 1979; 87B(2):109-15. DOI: 10.1111/j.1699-0463.1979.tb02412.x. View

3.
Young L, Stevens P, Kaijser B . Gram-negative pathogens in septicaemic infections. Scand J Infect Dis Suppl. 1982; 31:78-94. View

4.
Natanson C, Danner R, Elin R, Hosseini J, Peart K, Banks S . Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest. 1989; 83(1):243-51. PMC: 303668. DOI: 10.1172/JCI113866. View

5.
Natanson C, Eichenholz P, Danner R, Eichacker P, Hoffman W, Kuo G . Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med. 1989; 169(3):823-32. PMC: 2189288. DOI: 10.1084/jem.169.3.823. View